pH Pharma and Immunome Enter into Collaboration and License Agreement to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates in Oncology
October 21, 2019 08:00 ET
|
Immunome, Inc.
Companies to collaborate on the discovery of multiple novel antibody-drug conjugates that combine Immunome’s proprietary antibodies with pH Pharma’s novel toxin payloads Either company eligible to...